Enrichment Annotation By DAVID: KEGG Pathway | ||||
---|---|---|---|---|
Category | Term | Count | P_value | FDR |
KEGG_PATHWAY | hsa04115:p53 signaling pathway | 35 | 5.55E-011 | 6.85E-010 |
KEGG_PATHWAY | hsa04110:Cell cycle | 48 | 2.66E-009 | 3.28E-008 |
KEGG_PATHWAY | hsa05220:Chronic myeloid leukemia | 32 | 1.17E-007 | 1.45E-006 |
KEGG_PATHWAY | hsa05210:Colorectal cancer | 34 | 1.95E-007 | 2.41E-006 |
KEGG_PATHWAY | hsa05215:Prostate cancer | 35 | 2.82E-007 | 3.49E-006 |
KEGG_PATHWAY | hsa05200:Pathways in cancer | 87 | 6.71E-007 | 8.29E-006 |
KEGG_PATHWAY | hsa04310:Wnt signaling pathway | 48 | 1.95E-006 | 2.40E-005 |
KEGG_PATHWAY | hsa05212:Pancreatic cancer | 29 | 2.11E-006 | 2.61E-005 |
KEGG_PATHWAY | hsa04722:Neurotrophin signaling pathway | 41 | 4.29E-006 | 5.30E-005 |
KEGG_PATHWAY | hsa05214:Glioma | 26 | 4.85E-006 | 5.98E-005 |
KEGG_PATHWAY | hsa04114:Oocyte meiosis | 37 | 9.00E-006 | 1.11E-004 |
KEGG_PATHWAY | hsa05221:Acute myeloid leukemia | 23 | 4.13E-005 | 5.10E-004 |
KEGG_PATHWAY | hsa04120:Ubiquitin mediated proteolysis | 41 | 5.95E-005 | 7.34E-004 |
KEGG_PATHWAY | hsa05213:Endometrial cancer | 21 | 7.32E-005 | 9.03E-004 |
KEGG_PATHWAY | hsa04520:Adherens junction | 27 | 8.76E-005 | 1.08E-003 |
KEGG_PATHWAY | hsa05223:Non-small cell lung cancer | 21 | 1.35E-004 | 1.67E-003 |
KEGG_PATHWAY | hsa04662:B cell receptor signaling pathway | 26 | 1.51E-004 | 1.86E-003 |
KEGG_PATHWAY | hsa05222:Small cell lung cancer | 28 | 1.66E-004 | 2.05E-003 |
KEGG_PATHWAY | hsa04210:Apoptosis | 28 | 3.18E-004 | 3.91E-003 |
KEGG_PATHWAY | hsa04910:Insulin signaling pathway | 38 | 4.53E-004 | 5.57E-003 |
KEGG_PATHWAY | hsa04660:T cell receptor signaling pathway | 32 | 5.49E-004 | 6.76E-003 |
KEGG_PATHWAY | hsa04070:Phosphatidylinositol signaling system | 24 | 8.48E-004 | 1.04E-002 |
KEGG_PATHWAY | hsa03018:RNA degradation | 20 | 9.20E-004 | 1.12E-002 |
KEGG_PATHWAY | hsa05218:Melanoma | 23 | 1.14E-003 | 1.40E-002 |
KEGG_PATHWAY | hsa05219:Bladder cancer | 16 | 1.42E-003 | 1.74E-002 |
KEGG_PATHWAY | hsa04012:ErbB signaling pathway | 26 | 1.80E-003 | 2.20E-002 |
KEGG_PATHWAY | hsa04916:Melanogenesis | 28 | 2.78E-003 | 3.38E-002 |
KEGG_PATHWAY | hsa04914:Progesterone-mediated oocyte maturation | 25 | 3.38E-003 | 4.09E-002 |
KEGG_PATHWAY | hsa05216:Thyroid cancer | 12 | 3.54E-003 | 4.28E-002 |
KEGG_PATHWAY | hsa04720:Long-term potentiation | 21 | 3.74E-003 | 4.52E-002 |